Janina Markowska

Dendritic cell-based immunotherapy (DCVAC/OvCa) combined with second-line chemotherapy in platinum-sensitive ovarian cancer (SOV02): A randomized, open-label, phase 2 trial

2021 | Central Library of Charles University, First Faculty of Medicine, Third Faculty of Medicine

Publication